Skip to ContentSkip to Navigation
How to find us prof. dr. J.G.W. (Jos) Kosterink


Basic aspects of good manufacturing practice for PET-rediopharmaceuticals

Dried blood spot-methooe stap vooruit in tbc-behandeling

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Improving the aseptic transfer procedures in hospital pharmacies part A: Methods for the determination of the surface bioburden on ampoules and vials

Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients

Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

Safe use of radiopharmaceuticals in patients with chronic kidney disease: A systematic review

Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia

Read more


UMCG gaat strijd aan tegen geneesmiddelkaping door farmaceuten

Waarom pillen steeds beter werken (Dagblad van het Noorden)

Interview zorg instituut Nederland

Nog genoeg medicatie Covid-19, maar lange termijn is onzeker

Ziekenhuizen in Noord-Nederland gaan samenwerken om tekorten van medicatie te voorkomen

Waarom pillen steeds beter werken [Dagblad van het Noorden]

Read more